ESC Premium Access

Transcatheter aortic valve implantation in patients with uninterrupted vitamin k antagonist

Congress Presentation

About the speaker

Doctor Pierre Robert

University Hospital of Nimes, Nimes (France)
0 follower

9 more presentations in this session

Impact of left ventricular outflow tract sphericity on transcatheter heart valve hemodynamics and outcome after transcatheter aortic valve implantation

Speaker: Doctor E. Holy (Zurich, CH)


Blood erythropoietin independently predicts mid-term survival after post-procedural recovery from transcatheter aortic valve replacement in aortic stenosis: a prospective study

Speaker: Associate Professor S. Mas-Peiro (Frankfurt, DE)


11 years of transcatheter aortic valve implantation in a single centre and outcomes for all 1004 patient cases completed.

Speaker: Doctor P. Brennan (Belfast, GB)


Prevalence of transthyretin and immunoglobulin light chain cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement

Speaker: Doctor C. Nitsche (Vienna, AT)


Comparing outcomes and complications between transfemoral TAVI performed with or without echoguided puncture.

Speaker: Mr J. Bouteau (Tours, FR)


Access the full session

Poster Session 2 - Transcatheter valve intervention in the real world

Speakers: Doctor P. Robert, Doctor E. Holy, Associate Professor S. Mas-Peiro, Doctor P. Brennan, Doctor C. Nitsche...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb